RecruitingPhase 3NCT06500234

Nutrition Impact on Immunotherapy of Cancer

Phase III Study on the Relation of Nutrition and Immunotherapy of Cancer Patients

Sponsor

Qingdao Central Hospital

Enrollment

300 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Cancer Immunotherapy Nutrition Disorders Survival, Prosthesis

Summary

This study investigates nutritional status and outcomes of immuntherapy in cancer patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Megestrol Acetate and olanzapine and a drug called Starch powder 50 mg for people with cancer, immunotherapy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.